1. Racial diversity in melanoma research from 2015 to 2020: a cross‐sectional study.
- Author
-
Nickles, Melissa A., Kulkarni, Vishnutheertha, Garg, Swati P., Patel, Mit M., Kirchner, Allison, and Prabhu, Arpan V.
- Subjects
CROSS-sectional method ,CLINICAL trial registries ,MEDICAL personnel ,HISPANIC Americans - Abstract
Hispanics were the only group that were underrepresented, as all other races/ethnicities had nearly equal representation in melanoma clinical trials relative to the melanoma prevalence percentages. Dear Editor, Melanoma incidence is increasing in the United States without decreases in mortality.1 While Whites have the highest rates of melanoma, people of color (POC) experience a lower overall survival rate for cutaneous melanoma and are diagnosed at later stages.1 Recent data suggest that racial disparity in melanoma-specific survival has worsened since 2010 for Hispanics, non-Hispanic Blacks, and non-Hispanic Asian or Pacific Islanders.2 POC have historically been excluded from medical research, and the National Institutes of Health (NIH) now mandates the inclusion of women and minority groups in all NIH-funded clinical research. In this study, we sought to analyze the racial diversity of participants in recent melanoma research, specifically studies published from 2015 to 2020, to compare clinical trial data with the most recently published prevalence rates of melanoma. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF